Mechanisms of acute hypercalcemia in pediatric patients following the interruption of Denosumab

MLA

Michela Rossi, et al. Mechanisms of Acute Hypercalcemia in Pediatric Patients Following the Interruption of Denosumab. Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....62322218bc84b4d909c85d28d76cc542&authtype=sso&custid=ns315887.

APA

Michela Rossi, A. Del Fattore, Giulia Battafarano, E Levtchenko, Annalisa Deodati, Marco Cappa, H Segers, Graziamaria Ubertini, & Danilo Fintini. (2022). Mechanisms of acute hypercalcemia in pediatric patients following the interruption of Denosumab.

Chicago

Michela Rossi, A. Del Fattore, Giulia Battafarano, E Levtchenko, Annalisa Deodati, Marco Cappa, H Segers, Graziamaria Ubertini, and Danilo Fintini. 2022. “Mechanisms of Acute Hypercalcemia in Pediatric Patients Following the Interruption of Denosumab,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....62322218bc84b4d909c85d28d76cc542&authtype=sso&custid=ns315887.